Vitamin D and Calcium May Reduce Blood Pressure
As 25(OH)D levels increased, systolic blood pressure decreased significantly, even after accounting for calcium intake.
NKF 2017 Spring Meeting
Voclosporin Shows Promise as Lupus Nephritis Treatment
In a phase 2b trial, around half of patients taking the novel calcineurin inhibitor at a dose of 23.7 mg twice daily achieved complete remission at 48 weeks.
A Case of Calciphylaxis Without CKD or ESRD
A patient experienced painful skin ulcers despite having normal renal function.
Initial Low-Dose Etelcalcetide Feasible for SHPT Patients
At 18 months, PTH levels were within target for 67% and 68% of participants who initiated etelcalcetide at 2.5 mg and 5 mg, respectively.
Topically Applied Drug May Improve Hemodialysis Fistula Survival
In a study, vonapanitase did not improve primary patency compared with placebo, but did improve secondary patency and fistula use for hemodialysis.
Kidney Stones Common in Adult Patients With Horseshoe Kidneys
Adult patients with horseshoe kidneys have an estimated kidney stone incidence of 59%.
Sudden Cardiac Death Rate Remains High Among Hemodialysis Patients
Among hemodialysis patients, sudden cardiac death accounted for 12% more cardiovascular-related mortalities in 2013 than in 2009.
Testosterone Replacement May Delay CKD Progression
Study demonstrates decreased risk of end-stage renal disease and all-cause mortality.
Insurance Type Affects Initial Dialysis Modality Choice
ESRD patients aged 60-64 years with no insurance or who are on Medicaid are less likely to initiate peritoneal dialysis.
Sucroferric Oxyhydroxide Ups Phosphorus Control in SHPT
Nearly twice as many patients achieved the target phosphorus range after a year of taking the phosphate binder, regardless of iPTH level.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in NKF 2017 Spring Meeting
Loading... 
Loading...